Pharma Nord, founded in 1981 in Denmark, is a company that develops, produces and markets food supplements, herbal remedies and medicines with a solid scientific basis, based on optimal bioavailability, safety and documentation.

About Pharma Nord

Pharm Nord's initial idea was to compensate for the deficiencies of modern nutrition through food supplements with a high degree of bioavailability and a documented effect. The ActiveComplex Selenium+Zinc was successful in embodying this philosophy in a single product and allowed the creation of the first subsidiary companies in Sweden, England and Finland.

Over the years, Pharma Nord has repeatedly achieved a reputation as an innovative and visionary company in the nutraceutical sector. Furthermore, it was the first company to introduce coenzyme Q10 on the European market. The ActiveComplex Q10 Gold product was introduced in 1990 and has grown to become one of the leading Q10 products worldwide. This is just one of many examples that demonstrate how Pharma Nord has been at the forefront of the market, turning new knowledge into new products.

High standard and quality

All products are produced in accordance with current Good Manufacturing Practices (GMP) and in accordance with the requirements for drug manufacturing. This higher production standard offers a number of advantages for Pharma Nord and its customers.

Customers benefit from the control mechanisms and requirements that are built into pharmaceutical production, requiring documented consistency, safety and efficacy.

For Pharma Nord, this means that doctors, researchers and other health professionals trust their preparations and choose to use many of them in scientific studies, as well as recommending them to their patients as well.